Q38597443 | ATP and brain function |
Q37014556 | Calcium Homeostasis in Single Intact Smooth Muscle Cells |
Q47367892 | Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens |
Q81884920 | Dexamethasone up-regulates skeletal muscle maximal Na+,K+ pump activity by muscle group specific mechanisms in humans |
Q48255822 | Dissociation between short-term unloading and resistance training effects on skeletal muscle Na+,K+-ATPase, muscle function, and fatigue in humans |
Q43226261 | Effect of L-glutamine and n-butyrate on the restitution of rat colonic mucosa after acid induced injury |
Q34217591 | Effect of chronic renal failure on Na,K-ATPase alpha 1 and alpha 2 mRNA transcription in rat skeletal muscle |
Q26741120 | Effects of Age on Na(+),K(+)-ATPase Expression in Human and Rodent Skeletal Muscle |
Q70239344 | Effects of acute and chronic uremia on active cation transport in rat myocardium |
Q44300156 | Effects of electrical stimulation and insulin on Na+-K+-ATPase ([3H]ouabain binding) in rat skeletal muscle |
Q53955764 | Fatigue depresses maximal in vitro skeletal muscle Na(+)-K(+)-ATPase activity in untrained and trained individuals. |
Q41281006 | Human myocardial Na,K-ATPase concentration in heart failure. |
Q48008705 | Human myocardial Na,K-ATPase--quantification, regulation and relation to Ca. |
Q43871164 | Influence of development on Na(+)/K(+)-ATPase expression: isoform- and tissue-dependency. |
Q39127657 | Intense exercise up-regulates Na+,K+-ATPase isoform mRNA, but not protein expression in human skeletal muscle. |
Q51545730 | K+ supplementation increases muscle [Na+-K+-ATPase] and improves extrarenal K+ homeostasis in rats. |
Q37276538 | Myocardial Na,K-ATPase: Clinical aspects. |
Q44314974 | Na+,K+-ATPase trafficking in skeletal muscle: insulin stimulates translocation of both alpha 1- and alpha 2-subunit isoforms |
Q35102151 | Na+,K+-pump stimulation improves contractility in isolated muscles of mice with hyperkalemic periodic paralysis |
Q44527132 | Na+-K+-ATPase in rat skeletal muscle: content, isoform, and activity characteristics |
Q46427746 | Na+-K+-ATPase properties in rat heart and skeletal muscle 3 mo after coronary artery ligation |
Q35541873 | Na+-K+Pump Regulation and Skeletal Muscle Contractility |
Q52207265 | Quantification in crude homogenates of rat myocardial Na+, K(+)- and Ca(2+)-ATPase by K+ and Ca(2+)-dependent pNPPase. Age-dependent changes. |
Q37209186 | Quantification of Na+,K+ pumps and their transport rate in skeletal muscle: functional significance |
Q57806892 | Quantification of the total Na,K-ATPase concentration in atria and ventricles from mammalian species by measuring3H-ouabain binding to intact myocardial samples. Stability to short term ischemia reperfusion |
Q27687119 | Redox modification of proteins as essential mediators of CNS autophagy and mitophagy. |
Q72339964 | Reduced 3H-ouabain binding site (Na,K-ATPase) concentration in ventricular myocardium of dogs with tachycardia induced heart failure |
Q48871468 | Reduction of cerebral cortical [3H]ouabain binding site (Na+,K(+)-ATPase) density in dementia as evaluated in fresh human cerebral cortical biopsies |
Q38268864 | Regulation of the Na,K-pump in skeletal muscle |
Q44279875 | Sarcolemmal beta-adrenoceptors determined in rat ventricular heart biopsies with (-)-[3H]CGP-12177. |
Q54294395 | Unchanged [3H]ouabain binding site content but reduced Na+-K+ pump α2-protein abundance in skeletal muscle in older adults. |
Search more.